E
Eyal Herzog
Researcher at Mount Sinai Hospital
Publications - 125
Citations - 1124
Eyal Herzog is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 17, co-authored 124 publications receiving 974 citations. Previous affiliations of Eyal Herzog include New York Medical College & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Malnutrition as Assessed by Nutritional Risk Index is Associated with Worse Outcome in Patients Admitted with Acute Decompensated Heart Failure: An ACAP-HF Data Analysis:
Emad F. Aziz,Fahad Javed,Balaji Pratap,Dan Musat,Amjad Nader,Sandeep Pulimi,Carlos L. Alivar,Eyal Herzog,Marrick L. Kukin +8 more
TL;DR: Moderate and severe NRI score was associated with higher readmission and death rates as compared to the other two groups, and it is recommended to add NRI to further risk stratify these patients.
Journal ArticleDOI
Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials.
Partha Sardar,Saurav Chatterjee,Eyal Herzog,Ramez Nairooz,Debabrata Mukherjee,Jonathan L. Halperin +5 more
TL;DR: In patients with renal insufficiency, recommended doses of novel anticoagulants are noninferior and relatively safe compared with conventional antICOagulant, and this became statistically significant when evaluated using a fixed effects model.
Journal ArticleDOI
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents.
Georges El-Hayek,Franz H. Messerli,Sripal Bangalore,Mun K. Hong,Eyal Herzog,Alexandre M. Benjo,Jacqueline E. Tamis-Holland +6 more
TL;DR: In this article, the authors search PubMed, EMBASE, Scopus, and ClinicalTrials.gov databases from inception until October 2013 for randomized controlled trials that compared shorter versus longer DAPT duration after DES implantation.
Journal ArticleDOI
Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention
Georges El-Hayek,Anthony H. Gershlick,Mun K. Hong,Abel Casso Dominguez,Amerjeet Banning,Arash Ehteshami Afshar,Eyal Herzog,Jacqueline E. Tamis-Holland +7 more
TL;DR: From the RCT data, MV PCI appears to improve outcomes in patients with STEMI and MVCD, and there was a significantly lower risk of recurrent myocardial infarction and future revascularization with MV PCI.
Journal ArticleDOI
Early Activation of Metalloproteinases after Experimental Myocardial Infarction Occurs in Infarct and Non-infarct Zones.
TL;DR: MMPs are activated early after infarction both in the infarct and importantly, non-infarct zones of rat hearts following coranary artery ligation, as well as in sham operated rats to study activation of MMPs by zymography.